T-cell levels are prognostic in mantle cell lymphoma.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The purpose of this study was to investigate the impact of T-cell subsets on pathologic and clinical features including disease outcome in mantle cell lymphoma (MCL).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Clin Cancer Res

Title: Clinical cancer research : an official journal of the American Association for Cancer Research

Publisher: American Association for Cancer Research (AACR)

ISSN (Electronic): 1557-3265

ISSN (Print): 1078-0432

Publication date (Electronic): Dec 01 2014

Volume: 20

Issue: 23

Affiliations

[1 ] Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. Department of Oto-Rhino-Laryngology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

[2 ] Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

[3 ] Department of Medicine, Center for Haematology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.

[4 ] Department of Hematology and Coagulation, Stockholm South General Hospital, Stockholm, Sweden.

[5 ] Department of Internal Medicine, Hematology St. Görans Hospital, Stockholm, Sweden.

[6 ] Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. birgitta.sander@ki.se.

Article

Publisher Item ID: 1078-0432.CCR-14-0889

DOI: 10.1158/1078-0432.CCR-14-0889

PubMed ID: 25294911

SO-VID: da9e2524-06bc-4d63-9722-3298af1778b4

History

Data availability:

Comments

Comment on this article

scite_

Cited by 23

See all cited by

- Version 1